Repurposed drugs fail to slow disease progression in ALS trial
Neither memantine nor trazodone was able to slow amyotrophic lateral sclerosis (ALS) disease progression in a platform clinical trial.| ALS News Today
Neither memantine nor trazodone was able to slow amyotrophic lateral sclerosis (ALS) disease progression in a platform clinical trial.| ALS News Today
ALS is a neurodegenerative condition that causes muscle weakness, movement problems, and breathing issues. Learn more about ALS symptoms here.| ALS News Today
Marisa Wexler is a senior science writer for ALS News Today with an MS in cellular and molecular pathology. She covers the latest news and information on a variety of amyotrophic lateral sclerosis topics.| ALS News Today
ALS is a neurodegenerative condition that affects motor neurons. Learn about the causes and risk factors of ALS.| ALS News Today
Category archive page for News.| ALS News Today
ALS is a progressive neurological disorder that damages motor neurons. Learn more about types, causes, symptoms, diagnosis, and treatment.| ALS News Today
